
Since its founding in 1972, Tegal Corporation has been dedicated to the development and application of emerging technologies. In over 35 years of process development and equipment design, Tegal’s legacy is evident in the most advanced consumer and industrial products that incorporate microprocessors, magnetic memories, radio frequency ID chips, acoustic wave devices, sensors, LEDs, and an array of other semiconductor and MEMS devices fabricated by some of the world’s leading companies, including Tegal’s one-time parent, Motorola. Beginning in 2009, in response to a challenging industry and financial environment, Tegal began a process of transitioning out of semiconductor capital equipment and into areas with more opportunity for growth and profitability consistent with the company’s size and resources. Drawing on its historic technology leadership in manufacturing process technology that incorporated electro-magnetics, plasma physics, radio frequency control, and materials science, Tegal is currently engaged in the sponsorship of other related emerging technology areas, including photovoltaic (PV)-based solar power and medical devices. Tegal‘s objective is to employ its know-how and resources to pursue these opportunities for growth and profitability in order to enhance its value for over 6,000 public shareholders. Tegal is headquartered in Petaluma, California.
For the past several years Tegal has been in a process of consolidation and transition, driven by the financial crisis and downturn in the semiconductor and MEMS producing sectors, and worsened by our relatively weak strategic and financial position in those sectors. Our main focus has been to preserve as much value for stockholders as possible as we transition to a business model that avoids the high fixed costs of capital equipment and retains our capabilities to attract and exploit emerging technologies broadly related to the semiconductor and MEMS sectors. We successfully sold the majority of our operating and intellectual property assets in those sectors to companies that are much better positioned to benefit from those technologies. We are still engaged in the asset sale process and to date have completed investments in two companies – Sequel Power, in which we have secured an active management and operating role, and NanoVibronix. Our objective is to employ our know-how and resources to pursue these opportunities for growth and profitability in order to enhance our value as a public company. The Sequel Power model for large scale PV-based solar projects is unique in the industry and has won significant acclaim from governments, industrial companies and industry advocates for its innovation and prospect for success. Sequel Power has distilled its model of a vertically integrated power producer into a set of powerful simulation tools that can be applied across a variety of related businesses, including advisory, project management, project development, and underwriting. Tegal has supported the activities of Sequel Power through our direct efforts and through the investigation of related businesses and sectors in which we may make future investments.
NanoVibronix is a medical device company focused on creating products utilizing its proprietary low-intensity surface acoustic wave (SAW) technology. The company's unique, patented approach enables the transmission of low-frequency, low-intensity ultrasound waves through a variety of soft, flexible materials, including skin and tissue, enabling low-cost, breakthrough devices targeted at large, high-growth markets. NanoVibronix has developed a series of products that have been shown to prevent the formation of biofilm in long indwelling catheters. In addition, the company is developing a series of products directed at the treatment of chronic, non-healing wounds, a market whose growth is being fueled by an aging population and the rapidly increasing incidence of diabetes world-wide.
We are focused on working with Sequel Power and NanoVibronix to assist these companies in building successful enterprises. We may make additional investments in these or other technology-based companies in the future.
The Company was formed in December 1989 to acquire the operations of the former Tegal Corporation, a division of Motorola, Inc. Our predecessor company was founded in 1972 and acquired by Motorola, Inc. in 1978. We completed our initial public offering in October 1995. Beginning in 2002, the Company made a number of acquisitions and divestitures, including the following:
Beginning in the fiscal third quarter of 2009, following the acquisition of the DRIE product lines from AMMS, Tegal experienced a sharp decline in revenues related to its legacy Etch and PVD products, a result of the collapse of the semiconductor capital equipment market and the global financial crisis. The management and the Board of Directors of the Company considered several alternatives for dealing with this decline in revenues, including the sale of assets which the Company could no longer support. This resulted in the first of two major asset sales:
The Company retained the DRIE products which it had acquired from AMMS, along with the Compact cluster platform and the NLD technology that it had developed. However, the DRIE products and a small amount of associated spares and service revenue represented the sole source of the Company's income. Since the DRIE markets were also negatively impacted by the downturn in the semiconductor markets and the lack of available capital for new product development globally, it was not clear that DRIE sales alone would have been enough to support the Company, even with significant reductions in operating expenses. As a result, throughout most of fiscal 2010, the Company continued to evaluate alternative strategies, including the sale of its DRIE assets, the transition to a new business model and its voluntary liquidation. Following extensive due diligence, the Company established a new operation:
Following this investment in Sequel Power, the Company found a buyer for its DRIE assets:
After several months of research and due diligence in the area of medical devices, Tegal made a small investment in a medical device company with a promising new technology: